The rise of epigenetic targets for the development of novel antivirals

about

The dynamics of HCF-1 modulation of herpes simplex virus chromatin during initiation of infection.The antimicrobial agent C31G is effective for therapy for HSV-1 ocular keratitis in the rabbit eye model.

P2860

Q37015734-474FEF86-DF4B-4E2B-8A79-F49B14A60624 Q37590904-7F12A215-8F8B-4099-A713-F5C147BE6182

P2860

The rise of epigenetic targets for the development of novel antivirals

Item

http://www.wikidata.org/entity/Q36657906

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

The rise of epigenetic targets for the development of novel antivirals

@ast

The rise of epigenetic targets for the development of novel antivirals

@en

type

Item

label

The rise of epigenetic targets for the development of novel antivirals

@ast

The rise of epigenetic targets for the development of novel antivirals

@en

prefLabel

The rise of epigenetic targets for the development of novel antivirals

@ast

The rise of epigenetic targets for the development of novel antivirals

@en

P1476

The rise of epigenetic targets for the development of novel antivirals

@en

P2093

Thomas M Kristie

http://www.w3.org/2001/XMLSchema#string

P2860

Selective inhibition of BET bromodomains

PBAF chromatin-remodeling complex requires a novel specificity subunit, BAF200, to regulate expression of selective interferon-responsive genes.

An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions

Suppression of inflammation by a synthetic histone mimic

Chromatin-remodelling factor BRG1 selectively activates a subset of interferon-alpha-inducible genes

Epigenetic analysis of KSHV latent and lytic genomes.

Control of alpha-herpesvirus IE gene expression by HCF-1 coupled chromatin modification activities.

Epigenetic regulation of latent HSV-1 gene expression.

Activation of HIV transcription by the viral Tat protein requires a demethylation step mediated by lysine-specific demethylase 1 (LSD1/KDM1).

Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

P304

1359-1361

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1586/ERI.12.143

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233956884

http://www.w3.org/2001/XMLSchema#string

P698

23253311

http://www.w3.org/2001/XMLSchema#string

P932

4780314

http://www.w3.org/2001/XMLSchema#string

The rise of epigenetic targets for the development of novel antivirals

about

P2860

P2860

The rise of epigenetic targets for the development of novel antivirals

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932